John Paolini
Chief Tech/Sci/R&D Officer at KINIKSA PHARMACEUTICALS, LTD.
Net worth: 841 811 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eben Tessari | M | 42 | 9 years | |
| Michael Megna | M | 53 | 6 years | |
| Mark Ragosa | M | 50 | 6 years | |
| Sanj Patel | M | 54 | 9 years | |
| Felix Baker | M | 55 | 9 years | |
| Madelyn Zeylikman | F | - | 4 years | |
| Thomas Malley | M | 55 | 8 years | |
| Richard Levy | M | 66 | 5 years | |
| Kim Popovits | F | 65 | 6 years | |
| G. Cole | M | 68 | 4 years | |
| Stephen Biggar | M | 53 | 9 years | |
| Barry Quart | M | 67 | 9 years | |
| Tracey McCain | F | 56 | 6 years | |
| Rachel Frank | F | - | - | |
| Ross Moat | M | 43 | 5 years | |
| Johan Rutger Christenson | M | 65 |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Martina Struck | M | - | 6 years | |
| Melissa Manno | F | - | 7 years | |
| Alexandra Goll | M | 68 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Denis Lucquin | M | 67 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Bryan Supran | M | - | 8 years | |
| Chad Morin | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Heberlig | M | 49 | 5 years | |
| Thomas Beetham | M | 55 | 6 years | |
| Stephen Mahoney | M | 53 | 4 years | |
| Carsten Boess | M | 57 | 5 years | |
| Rasmus Holm-Jorgensen | M | 53 | 7 years | |
| Brendan Classon | M | - | - | |
| Michael Davidson | M | 67 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 4 years |
| John Davis | M | 56 | 9 years | |
| Bruce Rogers | M | 55 | 2 years | |
| Rajkumar Kannan | M | 61 | 1 years | |
| Brenda Cooperstone | M | 59 | 7 years | |
| Victor M. Clavelli | M | 51 | 3 years | |
| Annalisa D’Andrea | F | - | - | |
| Sophia Randolph | M | 56 | 8 years | |
| Michael Warner | M | - | 16 years | |
| Christopher Pierce | M | 44 | 1 years | |
| Michael Skynner | M | 55 | 3 years | |
| David Peritt | M | 60 | 1 years | |
| Clare Khan | M | 72 | 6 years | |
| Dakota Gallivan | M | - | 1 years | |
| Changyu Wang | M | 59 | 2 years | |
| Venkat Reddy | M | - | 2 years | |
| Arian Pano | M | - | 3 years | |
| Premal Patel | M | 54 | 2 years | |
| Chan Lee | M | - | 8 years | |
| Barry Ticho | M | 64 | 3 years | |
| Dolca Thomas | M | 53 | 4 years | |
| Christine Regan Lindenboom | F | 43 | - | |
| Arindam Bose | M | 71 | 6 years | |
| Narendra D. Lalwani | M | 71 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 7 years |
| Geno Germano | M | 63 | 7 years | |
| Ronald Shazer | M | 56 | 1 years | |
| Karin Jooss | M | 59 | 7 years | |
| Kevin Lee | M | 55 | 3 years | |
| Santhosh Palani | M | 41 | 3 years | |
| Richard Buller | M | 74 | 7 years | |
| Eric G. Mortsenson | M | 65 | 2 years | |
| Ian Taylor | M | 61 | 9 years | |
| Santiago Arroyo | M | 64 | 5 years | |
| Evert Schimmelpennink | M | 52 | - | |
| Valerie L. Legagneur | F | 50 | 10 years | |
| Carl Morris | M | 54 | 5 years | |
| Stacey T. Eisen | F | - | 1 years | |
| John C. Davis | M | 62 | 2 years | |
| Ekaterina Smirnyagina | M | 58 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | - |
| Susan E. Ward | M | - | 2 years | |
| Irina Apostolou | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 69 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Paolini
- Personal Network
